← All stocks

MAXCYTE, INC.

MXCT Net selling
CIK 0001287098 #4148 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$8.27K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$8.27K
1 of 1 sales
Net
−$8.27K
−$8.27K against sales at will

By person

13 insiders · 1 transaction
0.6×

Maher Masoud holds only 0.6 times base salary in stock. $387.13K of shares against $590.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Maher Masoud last reported holding, valued at $0.82, the price Common Stock was last bought or sold at on the open market here, on 17 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
$8.27K (1)
−$8.27K
151,669
0.1470%
$123.61K
+86.7%
Masoud Maher
President and CEO
475,000
0.4602%
$387.13K
+375.0%
Erck Stanley C
Director
428,749
0.4154%
$349.43K
+59.3%
DOUGLAS RICHARD
Director
260,998
0.2529%
$212.71K
+115.0%
Johnston John Joseph
Director
201,581
0.1953%
$164.29K
+42.0%
Ahuja Parmeet
Chief Financial Officer
187,500
0.1817%
$152.81K
Brooke William W
Director
181,300
0.1757%
$147.76K
+153.0%
Collins Cynthia
Director
111,310
0.1079%
$90.72K
BALTHROP PATRICK J
Director
80,998
0.0785%
$66.01K
+279.1%
Al-Wakeel Yasir B.
Director
80,998
0.0785%
$66.01K
+279.1%
Hemrajani Rekha
Director
70,314
0.0681%
$57.31K
+229.1%
Sandoval David I.
GENERAL COUNSEL
64,219
0.0622%
$52.34K
+39.9%
Soleymannezhad Ali
Chief Commercial Officer
59,439
0.0576%
$48.44K
+128.4%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 12
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 730,868
History held since 3 Aug 2021